Mixed
The current evidence is inadequate to establish a causal role of arsenic in diabetes due to methodological limitations in epidemiologic studies and the use of non-physiological concentrations in experimental studies.
While high arsenic exposure is linked to higher diabetes rates in some regions, scientists cannot yet say for sure that arsenic causes diabetes. The existing studies have significant flaws, such as not measuring individual exposure accurately or using unrealistic doses in lab experiments. More research is needed to confirm a cause-and-effect relationship.
In summary, the current available evidence is inadequate to establish a causal role of arsenic in diabetes.
Why this rating
This is the overarching conclusion of a systematic review of 48 studies.
Source
Arsenic Exposure and Type 2 Diabetes: A Systematic Review of the Experimental and Epidemiologic Evidence
Ana Navas‐Acién et al. · Environmental Health Perspectives · 2005
DOI 10.1289/ehp.8551
More from this paper
- Chronic exposure to high levels of arsenic in drinking water (typically >100 ppb) is associated with a significantly increased risk of developing type 2 diabetes, with a pooled relative risk of 2.52 in high-exposure populations.Moderate
- Arsenic exposure interferes with insulin signal transduction and glucose metabolism mechanisms, including the inhibition of insulin-stimulated glucose uptake and alteration of transcription factors like IUF-1 and PPARγ.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →